Alderys Overview
Latest Deal Type
M&A
(Announced)
Alderys General Information
Description
Developer of bioengineering products intended to offer plant-based microorganisms that can be used to fabricate plastics, elastomers, tires and other materials. The company's products are produced using compounds from renewable feedstock and micro-organisms capable of transforming non-food sugars and plant waste into profitable chemical compounds that reconcile the dual aim of economic performance and environmental respect, enabling researchers to get innovative technological industrial services for the fabrication of products that are indispensable.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Alderys Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 3. Merger/Acquisition |
28-May-2020 |
|
|
|
Announced |
Startup |
| 2. Accelerator/Incubator |
|
|
|
|
Completed |
Startup |
| 1. Early Stage VC |
|
|
|
|
Completed |
Startup |
Alderys Executive Team (1)
| Name |
Title |
Board Seat |
Contact Info |
| Dominique Thomas Ph.D |
Founder, President, Scientific Director, Chief Executive Officer & Board Member |
|
|
Alderys Board Members (3)
| Name |
Representing |
Role |
Since |
| Dominique Thomas Ph.D |
Alderys |
Founder, President, Scientific Director, Chief Executive Officer & Board Member |
000 0000
|
| Eric Marty |
Emertec Gestion |
Board Member |
000 0000
|
| Frank Chmitelin |
Alderys |
Board Member |
000 0000
|